Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 10, Pages 7898-7904Publisher
WILEY
DOI: 10.1002/jcb.26829
Keywords
AP1; curcumin; HBV; NF-kappa beta; Wnt/beta-catenin
Categories
Funding
- Arak University of Medical Sciences [1395.404]
Ask authors/readers for more resources
Curcumin is a yellow-orange powder derived from the Curcuma longa plant. Curcumin has been used extensively in traditional medicine for centuries. This component is non-toxic and shown different therapeutic properties such as antiinflammatory, anti-cancer, antiviral, anti-bacterial, anti-fungal, anti-parasites, and anti-oxidant. Hepatitis B virus (HBV) is a small DNA member of the genus Orthohepadnavirus (Hepadnaviridae family) which is a highly contagious bloodborne viral pathogen. HBV infection is a major public health problem with 2 billion people infected throughout the world and 350 million suffering from chronic HBV infection. Increasing evidence indicated that curcumin as a natural product could be employed in the treatment of HBV patients. It has been showed that curcumin exerts its therapeutic effects on HBV patients via targeting a variety of cellular and molecular pathways such as Wnt/beta-catenin, Apl, STAT3, MAPK, and NF-kappa B signaling. Here, we summarized the therapeutic effects of curcumin on patients who infected with HBV. Moreover, we highlighted main signaling pathways (eg, NF-kappa B, AP-1, and Wnt/beta-catenin signaling) which affected by curcumin in HBV infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available